FMS - Utang jangka cendhak perusahaan Fresenius Medical Care

Fresenius Medical Care relies on the loyalty of patients with kidney failure, which guarantees a stable cash flow. High barriers to entry and strict FDA oversight protect the business's position, while clinic automation stimulates growth. Credit obligations under one year demonstrate loan repayment dynamics, where 1.21 captures the current value of the indicator, allowing for an assessment of the risk of cash flow gaps.

To build a resilient portfolio, I analyze the issuer's solvency through the lens of its short-term liabilities. This metric aggregates all borrowings with a maturity of up to one year, reflecting the current pressure on liquidity. For the Fresenius Medical Care clinic network, such payments are covered by stable cash flow from vital dialysis procedures. The dynamics of current loans and borrowings allow for an assessment of capital management efficiency. An increase in this indicator requires a comparison with the business's operating profit.